Podcasts about mddirector

This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San Diego, CA.Launch Date: December 16, 2024Release Date: December 16, 2024Expiration Date: November 30, 2025FACULTYNaval Daver, MDDirector, Leukemia Research Alliance Program,Professor of MedicineDepartment of LeukemiaMD Anderson Cancer CenterThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link prior to listening to this podcast.

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: November 21, 2024Release Date: November 21, 2024Expiration Date: October 31, 2025FACULTYDouglas Dieterich, MDDirector, Institute for Liver Medicine at Mount SinaiProfessor of Medicine, Icahn School of Medicine at Mount SinaiThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

Optimize Heart Health & Prevent and Reverse Cardiovascular Disease with guest expert Dr. Caldwell Esselstyn, Jr.Let's dive into something crucial—heart health! Cardiovascular disease is the #1 killer of women globally.It does NOT have to be. In fact, heart disease kills more women than all types of cancer combined. You might not think about it every day, but what we eat and drink plays a major role in keeping our hearts healthy. There's so much to discover about the impact of diet on our cardiovascular system, and how simple changes can make a big difference.Curious about how to protect your heart and improve your health?TUNE IN and let's explore together with my esteemed guest expert and the director of the Heart Disease Prevention Program at the Cleveland Clinic, Caldwell Esselstyn, Jr., MD!In this episode, you will learn:The impact of diet on endothelial cell health and nitric oxide productionThe benefits and risks of different foods and beverages for heart healthHow plant-based nutrition can prevent and reverse cardiovascular diseaseThe role of green leafy vegetables in boosting nitric oxide levelsTop vegetables for promoting heart health, including the Doc's top picksSuccess stories of patients reversing heart disease with a plant-based dietDietary recommendations: the truth about caffeine, sugar, oil, alcohol, and animal protein to ensure better heart healthThe dangers of the typical American diet and its link to chronic illnessInsights on healthy fats and plant-based protein sourcesThe significance of outdoor activities and healthy eating habits for longevitySimple meal options for maintaining a heart-healthy, plant-based diet on the goHow caffeine affects nitric oxide production and heart healthThe impact of coffee on endothelial cell healthDifferences between decaffeinated and caffeinated coffee on the endothelial layerAbout our guest expert:Caldwell Esselstyn, Jr., MDDirector of Cleveland Clinic for Cardiovascular Disease PreventionAt age 90, former Olympian turned world-renown cardiovascular surgeon, Caldwell B. Esselstyn, Jr., is a tremendous example of how to eat to live disease-free! He is a Yale graduate (1956) and Western Reserve University M.D. (1961), is a renowned surgeon with a long-standing association with the Cleveland Clinic since 1961. He earned a gold medal in rowing at the 1956 Olympics and a Bronze Star as an Army surgeon in Vietnam. Dr. Esselstyn has held prominent roles at the Cleveland Clinic, including President of the Staff and Head of the Section of Thyroid and Parathyroid Disease, in addition to his role as the director of the heart health clinic.He has received numerous honors, including the Benjamin Spock Award for Compassion in Medicine (2005), Yale's Lifetime Achievement Award (2013), and the American College of Lifestyle Medicine's Lifetime Achievement Award (2016). His research on plant-based nutrition, documented in his bestselling book Prevent and Reverse Heart Disease, has over 150 scientific publications. Dr. Esselstyn currently leads the Cardiovascular Disease Prevention and Reversal Seminar at the Cleveland Clinic Center for Wellness and Preventive Medicine.He lives with his equally impressive wife, Ann (age 89!), in Ohio.Instagram:

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient, a 54-year-old woman with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: August 21, 2024Release Date: August 21, 2024Expiration Date: July 31, 2025FACULTYDouglas Dieterich, MDDirector, Institute for Liver Medicine at Mount SinaiProfessor of Medicine, Icahn School of Medicine at Mount SinaiThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they'll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).Launch Date: July 19, 2024Release Date: June 26, 2024Expiration Date: June 30, 2025FACULTYRobert Orlowski, MD, PhDProfessor of MedicineDirector, Section of MyelomaThe University of Texas, MD Anderson Cancer CenterNoopur Raje, MDDirector, Center for Multiple MyelomaMassachusetts General HospitalPeter Voorhees, MDChief, Plasma Cell Disorders DivisionAtrium Health / Levine Cancer InstituteClinical Professor of MedicineWake Forest University School of MedicineThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43

In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they'll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).Launch Date: July 19, 2024Release Date: June 26, 2024Expiration Date: June 30, 2025FACULTYRobert Orlowski, MD, PhDProfessor of MedicineDirector, Section of MyelomaThe University of Texas, MD Anderson Cancer CenterNoopur Raje, MDDirector, Center for Multiple MyelomaMassachusetts General HospitalPeter Voorhees, MDChief, Plasma Cell Disorders DivisionAtrium Health / Levine Cancer InstituteClinical Professor of MedicineWake Forest University School of MedicineThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43

In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they'll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).Launch Date: July 19, 2024Release Date: June 26, 2024Expiration Date: June 30, 2025FACULTYRobert Orlowski, MD, PhDProfessor of MedicineDirector, Section of MyelomaThe University of Texas, MD Anderson Cancer CenterNoopur Raje, MDDirector, Center for Multiple MyelomaMassachusetts General HospitalPeter Voorhees, MDChief, Plasma Cell Disorders DivisionAtrium Health / Levine Cancer InstituteClinical Professor of MedicineWake Forest University School of MedicineThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:Rationale for targeting CELMoDs in NHLMechanism of action of CELMoDsKey studies and available efficacy and safety data with investigational CELMoDs in NHLKey ongoing clinical trials of CELMoDs in NHLStrategies to boost NHL clinical trial diversity among underserved communitiesPresenters: Julio C. Chavez, MD, MSAssociate MemberDepartment of Malignant HematologyICE-T Clinical Research Medical Director for Hematologic MalignanciesH. Lee Moffitt Cancer Center and Research InstituteAssociate ProfessorUniversity of South FloridaTampa, FloridaAlan Skarbnik, MDDirector, Lymphoma and CLL ProgramDirector, Immune Effector Cell Therapeutics ProgramNovant Health Cancer InstituteCharlotte, North CarolinaContent based on an online CME program supported by educational grants from Bristol-Myers Squibb.Link to full program:https://bit.ly/45YXoZI

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.Launch Date: May 2, 2024Release Date: May 2, 2024Expiration Date: April 30, 2025FACULTY BIOJesús G. Berdeja, MDDirector of Multiple Myeloma ResearchThe Greco-Hainsworth Tennessee Oncology Centers for ResearchJoseph Mikhael, MD, MEd, FRCPC, FACPProfessor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer CenterChief Medical Officer, International Myeloma FoundationConsultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research InstituteAdjunct Professor, College of Health Solutions, Arizona State UniversitySaad Usmani, MDChief, Myeloma ServiceMemorial Sloan Kettering Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.Launch Date: May 2, 2024Release Date: May 2, 2024Expiration Date: April 30, 2025FACULTY BIOJesús G. Berdeja, MDDirector of Multiple Myeloma ResearchThe Greco-Hainsworth Tennessee Oncology Centers for ResearchJoseph Mikhael, MD, MEd, FRCPC, FACPProfessor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer CenterChief Medical Officer, International Myeloma FoundationConsultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research InstituteAdjunct Professor, College of Health Solutions, Arizona State UniversitySaad Usmani, MDChief, Myeloma ServiceMemorial Sloan Kettering Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.Launch Date: May 2, 2024Release Date: May 2, 2024Expiration Date: April 30, 2025FACULTY BIOJesús G. Berdeja, MDDirector of Multiple Myeloma ResearchThe Greco-Hainsworth Tennessee Oncology Centers for ResearchJoseph Mikhael, MD, MEd, FRCPC, FACPProfessor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer CenterChief Medical Officer, International Myeloma FoundationConsultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research InstituteAdjunct Professor, College of Health Solutions, Arizona State UniversitySaad Usmani, MDChief, Myeloma ServiceMemorial Sloan Kettering Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this podcast, experts Donna Ryan, MD, and Renslow Sherer, MD, discuss how to manage the health risks posed by COVID-19 infection and long COVID in individuals with metabolic syndrome or obesity.First, Dr Ryan presents an overview of the relationship between COVID-19 and weight, including the mechanisms of how obesity may drive COVID-19 disease and how COVID-19 may in turn worsen obesity, through both immunologic and social or societal drivers.Dr Ryan also discusses the relationship between obesity and the risk for long COVID.In his segment, Dr Sherer discusses COVID-19 vaccination and antiviral therapy within the context of obesity and metabolic syndrome. Dr Sherer also delves into detail on how obesity-related risk factors or comorbidities may affect treatment decisions and presents strategies on individualizing treatment, including in patients with long COVID.This episode includes results from several reviews and meta-analyses examining the relationship between vaccination, as well as an observational study investigating the impact of nirmatrelvir/ritonavir therapy on long COVID in vaccinated patients.Presenters:Donna Ryan, MDProfessor Emerita Pennington Biomedical Research Center New Orleans, Louisiana Renslow Sherer, MDDirector of the International HIV Training Center Professor of MedicineInfectious Diseases and Global Health Department of Medicine University of Chicago Department of Medicine Chicago, IllinoisContent based on an online CME program supported by independent educational grants from Pfizer.Link to full program:https://bit.ly/46yuChS

On this episode of We Talk Health, Dr. Adam Summerlin returns to share what's new at the Imaging Center, and we introduce you to Dr. Julie Miller, who is the Director of Breast Imaging Services. What does a radiologist do? What is a high-risk screening and who is it for? What's new in imaging and mammography? Find out all this and more!If you'd like to schedule an appointment to have a mammogram, give the West Tennessee Imaging Center a call at 731-541-8850.Guests:Adam Summerlin, MDMedical Director of RadiologyJulie Miller, MDDirector of Breast Imaging Services Host:Kara MobleySocial Media CoordinatorReferences:- Podcast Ep 121. - Mammography Self Referal - CLICK HERE- Breast Cancer Risk Assessment Tool - CLICK HERE- Society of Breast Imaging - End the Confusion

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisTrinh P. Vu, PharmD, BCIDPClinical Pharmacy Specialist in Infectious DiseasesDepartment of Pharmaceutical ServicesEmory University Hospital MidtownAtlanta, GeorgiaTo download the slides: bit.ly/3oHKC09To view the full online program: bit.ly/4201xcO

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisTrinh P. Vu, PharmD, BCIDPClinical Pharmacy Specialist in Infectious DiseasesDepartment of Pharmaceutical ServicesEmory University Hospital MidtownAtlanta, GeorgiaTo download the slides: bit.ly/3oHKC09To view the full online program: bit.ly/4201xcO

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisTrinh P. Vu, PharmD, BCIDPClinical Pharmacy Specialist in Infectious DiseasesDepartment of Pharmaceutical ServicesEmory University Hospital MidtownAtlanta, GeorgiaTo download the slides: bit.ly/3oHKC09To view the full online program: bit.ly/4201xcO

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/deep-dive-into-oab-in-the-elderly-your-questions-answeredSummaryIn this activity, Dr. Matt Rosenberg akes a deeper dive evaluation and management of OAB in elderly patients. Dr Rosenberg answers the five most commonly asked questions by clincians during recent presentations on Overactive Bladder (OAB) at NACE live virtual symposiaLearning ObjectivesUpon completion of this activity, learners should be able to:Identify lower urinary tract symptoms (LUTS) and the differential diagnosis in elderly patients.Contrast clinically relevant differences between currently available agents for OAB.Individualize the management of OAB in elderly patients based on their comorbidities, medical needs, and living environment.Moderator:Gregg Sherman, MDChief Medical OfficerNational Association for Continuing EducationPlantation, FLFaculty:Matt T. Rosenberg, MDDirector, Mid-Michigan Health CentersJackson, MIThis activity is accredited for CME/CE Credit.For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/deep-dive-into-oab-in-the-elderly-your-questions-answeredThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 Contact hours (which includes 0 hours of pharmacology).This educational activity is supported by an educational grant from Urovant Sciences, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode, Renslow Sherer, MD, and Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, discuss patient cases that illustrate key concepts for managing ambulatory patients with acute COVID-19 infection, including:A young, otherwise healthy patientAn older patient with multiple comorbidities A patient with immunocompromiseA patient requiring emergency department-level carePresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisJason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRNProfessorSchool of NursingJohns Hopkins UniversityNurse PractitionerDepartment of Infectious DiseasesJohn G. Bartlett Specialty PracticeBaltimore, MarylandTo download the slides:http://bit.ly/3G9IrJxTo view the full online program:https://bit.ly/3TqnNIX

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:Rapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Monoclonal antibody treatment (bebtelovimab)Long COVIDPresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisTrinh P. Vu, PharmD, BCIDPClinical Pharmacy Specialist in Infectious DiseasesDepartment of Pharmaceutical ServicesEmory University Hospital MidtownAtlanta, GeorgiaTo download the slides:https://bit.ly/3TkT7sJTo view the full online program:https://bit.ly/3TqnNIX

In this episode, Erika P. Hamilton, MD, and Komal Jhaveri, MD, discuss their approaches to and key studies for current management of patients with HER2-positive breast cancer. The discussion includes: Optimizing systemic therapy for patients with HER2-positive early breast cancer based on disease characteristics and riskSequencing available therapies for patients with HER2-positive metastatic disease, including new data on first- and second-line therapy and how to manage patients with central nervous system metastasesManaging common adverse events associated with HER2-targeted therapyPresenters:Erika P. Hamilton, MDDirector, Breast and Gynecologic Cancer Research ProgramDrug Development UnitSarah Cannon Research InstituteInvestigatorTennessee OncologyNashville, TennesseeKomal Jhaveri, MDAssistant Professor of MedicineWeill Cornell Medical CollegeAssociate Attending PhysicianBreast Medicine ServiceDepartment of MedicineMemorial Sloan Kettering Cancer CenterNew York, New YorkSee full program:  https://bit.ly/3oBdd45

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.Faculty Presenters:James R. Gavin III, MD, PhDClinical Professor of Medicine, Emory UniversityChief Medical Officer, Healing Our Village, Inc.Atlanta, GeorgiaRobert Busch, MDDirector of Clinical ResearchAlbany Med Faculty Practice, Community Endocrine GroupAlbany, New York  Pablo F. Mora, MD, FACE, MSc, CDCESEndocrinologist, North Texas Diabetes & EndocrinologyClinical Professor, Division of Endocrinology at University of Texas Southwestern Medical CenterDallas, Texas 

On Saturday, June 4th, our host Dr. Marianne Ritchie talked with Dr. Mark Lazarus, a Professor of Orthopaedics who is internationally recognized for his research and surgical skills in shoulder and elbow disorders.Dr. Lazarus has lectured all over the world and has authored numerous articles on all aspects of shoulder and elbow surgery. He specializes in shoulder and elbow replacement and has helped design several shoulder prostheses, and also has been an innovator in the field of arthroscopic shoulder surgery, including rotator cuff repair and stabilization surgery.Learn learn tips about the prevention of a shoulder or elbow injury and what questions you might want to ask before surgery.Mark D. Lazarus, MDDirector, Shoulder and Elbow Service,The Rothman Orthopaedic InstituteProfessor of Orthopaedic Surgery Health, Sidney Kimmel Medical College Thomas Jefferson University

On Saturday, April 23rd, our host Dr. Marianne Ritchie welcomed the return of Dr. Paul Offit, a world-renowned expert in the study of viruses, vaccines, and immunology.He talked about updates on the COVID vaccine, boosters, and everything we've learned in these past two years since the initial outbreak of COVID-19.Mark Tykocinski, MDPaul A. Offit, MDDirector of the Vaccine Education Center and Professor of Pediatrics in the Division of Infectious Diseases at CHOPMaurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of PennYour Real Champion® – “Yes, We Can-dy! A Kiss for Billy Penn”Mr. Rich Loughran is an eighth-grade teacher from Newtown Middle School who not only teaches history but makes history!He and fellow teacher Matt McCarthy along with eight students were guests of Lt. Governor Fetterman and observed a session of the PA State Senate. They learned the value of being engaged citizens as they heard their idea presented in a Senate Resolution – to make the Hershey Kiss the state candy.Front row – Rich Loughran, Senator Collett, Cameron Forsyth, Varsha Garimella, Lana Hakma, Emily Kennedy, Elaine Liaw, Audrey Thomson, and Kacie Welch [missing Kaitlyn Landers], Matt McCarthyBack row – Senators Santarsiero and DiSanto.Each week we highlight the Real Champions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. Know someone who should be featured? Nominate them now!Check out all of our past Champions →

In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target with promising results in PD-L1-positive NSCLC. The episode includes a review of phase II data on the use of tiragolumab plus atezolizumab in NSCLC, the use of PD-L1 as a marker of response, the potential role of anti-TIGIT therapies in solid tumors, and ongoing trials in lung cancer including SKYSCRAPER-01, SKYSCRAPER-02, SKYSCRAPER-03, and SKYSCRAPER-05. Presenters:Jyoti D. Patel, MDProfessor of MedicineDivision of Hematology and OncologyMedical Director for Thoracic OncologyAssistant Director for Clinical ResearchAssociate Vice Chair of Clinical ResearchDepartment of MedicineRobert H. Lurie Comprehensive Cancer CenterNorthwestern UniversityChicago, Illinois Ani  Balmanoukian, MDDirector of Thoracic OncologyMedical OncologyThe Angeles Clinic and Research Institute, a Cedars-Sinai AffiliateLos Angeles, CaliforniaLink to the complete program, including an online text module with downloadable slidesets, ClinicalThought commentaries, and an additional podcast on this topic:https://bit.ly/38qVCH7

In this episode, Renslow Sherer, MD, discusses what is known to date regarding long COVID, also known as postacute sequelae of COVID-19 infection, including:Possible causes and risk factorsSigns and symptomsClinical managementTreatment options under considerationRole of vaccinationPresenter: Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisReview the downloadable slideset and the full program at: https://bit.ly/3Ix8uZg

A group of leading experts in pediatric neurology and movement disorders attended a virtual roundtable to discuss diagnostic, symptomatic, and research aspects of aromatic L-amino acid decarboxylase (AADC) deficiency.AADC deficiency is characterized by a defect in the dopa decarboxylase or DDC gene; this dysfunction leads to reduced production of the critical neurotransmitters dopamine, norepinephrine, epinephrine, and melatonin. As a result, patients with AADC deficiency can suffer deficits in vital motor function.The symptoms of this very rare genetic disorder usually appear before children reach one year of age. Patients with severe symptoms rarely survive beyond age 10. Although patients with moderate symptoms can live into adulthood, those afflicted with AADC deficiency often experience developmental disability and can require lifelong care. The participants included:Philip L. Pearl, MD Director, Epilepsy and Clinical Neurophysiology, Boston Children's HospitalWilliam G. Lennox Chair and Professor of Neurology, Harvard Medical SchoolBoston, MAWarren A. Marks, MDMedical Director, Movement DisordersCook Children's Jane and John Justin Neurosciences CenterFort Worth, TXPaul Wuh-Liang Hwu, MD, PhDProfessor, Department of Pediatrics and Medical GeneticsNational Taiwan University HospitalTapei, TaiwanIrina A. Anselm, MDDirector of the Mitochondrial Program and Co-Director of the Neurometabolic Program, Boston Children's HospitalAssistant Professor of Neurology, Harvard Medical SchoolBoston, MAJennifer O'Malley, MD, PhDClinical Assistant Professor, Neurology & Neurological Sciences, Stanford MedicinePediatric Neurologist, Stanford Children's HealthStanford, CAModerated by Dr. Pearl, the roundtable participants described the first recognized case of AADC deficiency, and the fact that the prevalence and incidence of the condition is not yet clear. One problem is that the presentation of infants with AADC deficiency is not very specific, and a large number of patients are probably not yet diagnosed, said Dr. O'Malley. Unexplained hypotonia is a useful sign, she explained, which clinicians can use to go down the path to diagnosis. Dr. Marks commented that when children present with movement disorders at his center, he has a very low threshold to begin genetic testing for AADC deficiency, which will rapidly eliminate or confirm the diagnosis. Dr. Hwu emphasized that clinical recognition is the first step: Once you make one diagnosis, it isn't too difficult to identify the second patient.Symptomatic treatment can be useful, particularly in patients with milder forms of AADC deficiency, said Dr. Anselm. For example, similar to Parkinsonism, dopamine agonists can have positive results, but dyskinesias are problematic.Gene therapy holds promise, according to Dr. Hwu, but he cautioned that even if successful, a good deal of movement training and patience will be required to gain movement control.Drs. O'Malley and Anselm believe that collaboration and education among the different disciplines (e.g., child neurologists and physiatrists) is key to improving recognition of AADC deficiency and gaining early treatment.

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir—for nonhospitalized adults with mild to moderate COVID-19, including:EPIC-HR study of nirmatrelvir (PF-07321332) plus ritonavirSafety dataEfficacy dataMOVe-OUT study of molnupiravirSafety dataEfficacy dataRoles in treatment of COVID-19Timing of treatmentPresenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisReview the downloadable slideset at:https://bit.ly/31wi1QiLink to full program:https://bit.ly/3EH2485

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 vaccine efficacy, including:Third dosesBooster dosesMixing and matching booster dosesPresenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisReview the downloadable slideset at:https://bit.ly/3Fl0yZVLink to full program:https://bit.ly/3EH2485

In this episode, Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, answer questions from a live webinar providing their thoughts on how to select the optimal therapy for patients with relapse/refractory multiple myeloma. Topics include:Treatment after first relapsedOptimal use of CAR T-cell therapyWhen to use selinexor and belantamab mafodotinCOVID-19 vaccinations for patients with myelomaPresenters:Paul G. Richardson, MDR. J. Corman Professor of MedicineHarvard Medical SchoolClinical Program LeaderDirector of Clinical ResearchJerome Lipper Multiple Myeloma CenterDana-Farber Cancer InstituteBoston, MassachusettsNina Shah, MDProfessor of Clinical MedicineDivision of Hematology-OncologyDepartment of MedicineUniversity of California San FranciscoSan Francisco, CaliforniaPeter M. Voorhees, MDDirector, Medical Operations and Outreach ServicesDepartment of Hematology/OncologyLevine Cancer Institute, Atrium HealthCharlotte, North CarolinaContent based on an online CME program supported by educational grants from Bristol-Myers Squibb, GlaxoSmithKline, Karyopharm, Oncopeptides, and Sanofi Genzyme.Link to full program:https://bit.ly/2UIhXcL

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell discuss promising advances in the field of HIV vaccine research and how we can prepare for optimal rollout of an eventual HIV vaccine. Presenters:Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD , PGD (Research Ethics), MBE (Research Ethics), CIPSenior Principal Clinical Research ScientistCenter for Microbiology ResearchKEMRIResearch ProfessorDepartments of Global Health and Obstetrics and GynecologyUniversity of Washington,Nairobi, KenyaSeattle, WashingtonPeter Godfrey-Faussett, MBBS, FRCP(UK)Science AdvisorUnited Nations Joint Programme on HIV (UNAIDS)Professor of Infectious Diseases and International HealthLondon School of Hygiene and Tropical MedicineLondon, United KingdomNina Russell, MDDirector for TB and HIV PreventionBill & Melinda Gates FoundationSeattle, WashingtonLink to full series:  https://bit.ly/2UgrQ12Link to the HIV unmuted series from IAS: https://hivunmuted.iasociety.org/Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

Recorded Live May 20, 2021 While new COVID-19 cases have fallen to their lowest levels since September, many people are still hesitant to get a shot. This live Q&A event addressed your questions and concerns about the vaccines and how to stay safe in public, social and family circles as things begin to open up across the country. The Experts: Lindsey Gottlieb, MDDirector of Infection Prevention, Mount Sinai Morningside Warren P. Hebert, Jr., DNP, RNNursing Professor, Loyola University of New Orleans, CEO, HomeCare Association of Louisiana Virginia Caine, MDDirector and Chief Medical Officer, Marion County (IN) Public Health Department Associate Professor of Medicine, Indiana University School of Medicine, Division of Infectious Diseases

Recorded Live May 20, 2021 While new COVID-19 cases have fallen to their lowest levels since September, many people are still hesitant to get a shot. This live Q&A event addressed your questions and concerns about the vaccines and how to stay safe in public, social and family circles as things begin to open up across the country. The Experts: Lindsey Gottlieb, MDDirector of Infection Prevention, Mount Sinai Morningside Warren P. Hebert, Jr., DNP, RNNursing Professor, Loyola University of New Orleans, CEO, HomeCare Association of Louisiana Virginia Caine, MDDirector and Chief Medical Officer, Marion County (IN) Public Health Department Associate Professor of Medicine, Indiana University School of Medicine, Division of Infectious Diseases

The August 8, 2020 NACE COVID-19 Update was recorded live during the Emerging Challenges and Clinical Updates for Primary Care virtual symposium. This segment features moderator  Neil Skolnik. MD,  and Public Health Experts Leana Wen, MD, and Seema Yasmin, MD. In this update, Dr. Skolnik presents an update of the pandemic, and Dr Wen and Dr Yasmin present evidence-based information about the epidimiology and considerations surrounding the need for appropriate reopening of schools for the summer fall period in the United States. Faculty Neil Skolnik, MD Professor of Family and Community Medicine Sidney Kimmel Medical College Thomas Jefferson UniversityPhiladelphia, PA Leana S. Wen, MD, MSc Visiting Professor, Health Policy and Management Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity George Washington University School of Public Health Washington, DCSeema Yasmin, MDDirector, Stanford Health Communication InitiativeClinical Assistant Professor, Stanford UniversitySchool of MedicineStanford, CAThis activity is not certified for CME/CE credit.

This week special guest Dr. Seema Yasmin (@DoctorYasmin) joins Dr. Leana Wen (@DrLeanaWen) and Moderator Dr. Neil Skolnik (@NeilSkolnik) for the Update.  Dr Wen provides a  public health update and presents four concepts for evaluating your risk of infection as practices reopen their doors. Dr Yasmin Dr. Yasmin's focuses on racial disparities in health care and the impact on  COVID-19 patients and practice. This NACE COVID-19 Update was recorded live during the Emerging Challenges in Primary Care May 30, 2020 virtual symposium. Be sure to read Dr Wen's and Dr Yasmin recent articles listed in the References at the end of this summary. FacultyNeil Skolnik, MD Professor of Family and Community Medicine Sidney Kimmel Medical College Thomas Jefferson UniversityPhiladelphia, PA Leana S. Wen, MD, MSc Visiting Professor, Health Policy and Management Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity George Washington University School of Public Health Washington, DCSeema Yasmin, MDDirector, Stanford Health Communication InitiativeClinical Assistant Professor, Stanford UniversitySchool of MedicineStanford, CAThis activity is not certified for CME/CE credit.ReferencesAPM Research Lab Staff. THE COLOR OF CORONAVIRUS:COVID-19 Deaths by race and ethnicity in the U.S., May 27, 2020 APM Research Lab.Braun L. Breathing race into the machine: the surprising career of the spirometer from plantation to genetics. Minneapolis: University of Minnesota Press, 2014.Chowkwanyun, Merlin,Reed, Adolph L. Racial Health Disparities and Covid-19 — Caution and Context. New England Journal of Medicine, May 6, 2020. Edwards, Erika. African Americans 'disproportionately affected' by coronavirus, CDC report finds. NBC News, April 8 2020. Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826‐833. doi:10.2105/AJPH.2004.060749Molina N. Fit to be citizens? Public health and race in Los Angeles, 1879-1939. Berkeley: University of California Press, 2006.Roberts SK. Infectious fear: politics, disease, and the health effects of segregation. Chapel Hill: University of North Carolina Press, 2009.Strings, S. It's Not Obesity, It's SlaveryThe New York Times, May 25, 2020Wen, Leana S.  Four concepts to assess your personal risk as the U.S, . Wen, Leana S, 100,000 deaths later, there are no more excuses, The Washington Post, May 21, 2020. Yasmin, Seema, How Medicine Perpetuates the Fallacy of Race, Medscape, March 11, 2020.